Massachusetts Eye and Ear is a specialty hospital located in Boston, Massachusetts, United States, which focuses on ophthalmology, otolaryngology, and related medicine and research.

There are 41 beds in Massachusetts Eye and Ear Infirmary.

During the past decade, Massachusetts Eye and Ear Infirmary conducted 98 clinical trials. In the 10-year time frame, 98 clinical trials started and 40 clinical trials were completed, i.e. on average, 40.8% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 22 clinical trials were completed. i.e. 57.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Massachusetts Eye and Ear Infirmary" #1 sponsor was "Massachusetts Eye and Ear Infirmary" with 59 trials, followed by "Reza Dana, MD" with 5 trials sponsored, "Applied Genetic Technologies Corp" with 3 trials sponsored, "Aura Biosciences" with 3 trials sponsored and "Kristina Simonyan" with 3 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts Eye and Ear Infirmary" #1 collaborator was "Massachusetts Eye and Ear Infirmary" with 7 trials as a collaborator, "National Eye Institute (NEI)" with 7 trials as a collaborator, "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 5 trials as a collaborator, "Ohio State University" with 3 trials as a collaborator and "Stanford University" with 3 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts Eye and Ear Infirmary" are "Corneal Neovascularization" (6 trials), "Choroidal Melanoma" (4 trials), "Glaucoma" (4 trials), "Vestibular Schwannoma" (4 trials) and "Dry Eye" (3 trials). Many other conditions were trialed in "Massachusetts Eye and Ear Infirmary" in a lesser frequency.

Most popular intervention types in "Massachusetts Eye and Ear Infirmary" are "Drug" (81 trials), "Device" (23 trials), "Other" (18 trials), "Biological" (13 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "LX211" (3 trials), "0.9% NaCl & Refresh Liquigel" (2 trials), "Acetaminophen" (2 trials) and "Avastin® (bevacizumab)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts Eye and Ear Infirmary" are 144 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Massachusetts Eye and Ear Infirmary". undefined are not yet recruiting, 23 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 73 completed trials in Massachusetts Eye and Ear Infirmary, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts Eye and Ear Infirmary, 27 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 29 trials that are defined as “Not Applicable".

Massachusetts Eye and Ear Infirmary has several departments that took part in Clinical trials: "Schepens Eye Research Institute" - 8 trials